Boothwyn Pharmacy

Name

Boothwyn Pharmacy

Legal name

Boothwyn Pharmacy

Website

https://boothwynpharmacy.com

Company type

Private

Founded year

1933

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Compounding Pharmacy

NAICS

Pharmacies and Drug Retailers (456110), Pharmaceutical Preparation Manufacturing (325412)

SIC

Retail-Drug Stores And Proprietary Stores (5912), Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM), Pet Pharmacy Retail (Prescription) (CRALAHAD)

Keywords

• Compounding pharmacy services
• Custom medication compounding
• Veterinary pharmacy services
• Sterile compounding preparations
• Prescription fulfillment services

Headquarters

HQ city

Kennett Square

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Compounded Medications: Boothwyn Pharmacy generates revenue through preparation and dispensing of customized compounded medications to patients, veterinarians, and through physician prescriptions. The pharmacy tailors medications to meet specific patient needs and requirements.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Boothwyn Pharmacy is a specialty compounding pharmacy that prepares customized medications for human and animal patients on a prescription basis. It offers both sterile and non-sterile compounding following USP standards, with every dose third-party laboratory tested, and dispenses compounded preparations directly to patients and through physician and veterinarian referrals with 2-day shipping nationwide.

Product overview

Boothwyn Pharmacy is a specialty compounding pharmacy offering customized medications for multiple customer segments: physicians, veterinarians, human patients, and animal lovers (pet owners). The core offering is their compounding pharmacy services, which include sterile and non-sterile preparations tailored to individual patient needs. GLP-1 testing services provide quality verification for compounded formulations. The pharmacy operates with a focus on regulatory compliance, USP standards adherence, and third-party laboratory testing to ensure consistency and safety in every dose.

Differentiator

Problem solved

Functional benefit

Products and services

• Compounding Pharmacy Services Customized compounded medications prepared in both sterile and non-sterile forms to meet individual patient needs for human and veterinary patients, including hard-to-get medications and compliance-friendly dosage forms, dispensed via prescription with 2-day shipping.
• GLP-1 Testing Services Third-party laboratory testing services for compounded GLP-1 medications to verify authenticity, potency, and quality of formulations.

Quantifiable outcome

• 90% of orders shipped within 48 hours

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Revelation Pharma: Multi-site compounding pharmacy platform (parent of Wedgewood and other regional compounders); competes with Boothwyn across both human and veterinary compounding at greater scale and formulary breadth.

Direct peers

• US Compounding Pharmacy: PCAB-accredited 503A compounding pharmacy offering customized sterile and non-sterile preparations for human and veterinary patients; directly comparable regulatory positioning and prescriber-targeted service model.
• Wedgewood Pharmacy: Large specialty compounding pharmacy with deep veterinary and human compounding offerings; operates a similarly diversified prescriber referral model and ships nationally, making it Boothwyn's closest direct competitor across both verticals.
• AnazaoHealth: Specialty compounding pharmacy with nuclear pharmacy and customized sterile/non-sterile preparations; overlapping compounding capabilities and physician-targeted referral channels.
• McGuff Compounding Pharmacy Services: Independent compounding pharmacy serving physicians, veterinarians, and patients with sterile and non-sterile preparations; comparable product breadth and B2B referral GTM overlap directly with Boothwyn.

Others

• Medisca: Global distributor of compounding APIs, vehicles, and equipment plus formulation support to pharmacies like Boothwyn; functions as an upstream supplier/enabler in the compounding value chain.
• PCCA (Professional Compounding Centers of America): Supplies APIs, excipients, base formulas, and training to compounding pharmacies including Boothwyn; adjacent ecosystem participant that defines the compounding practice standards Boothwyn follows.

Emerging players

• Empower Pharmacy: Fast-growing national 503A/503B compounding pharmacy offering human hormone, sterile, and non-sterile preparations; competes with Boothwyn on price and scale, especially for human compounding and HRT demand.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/boothwynpharmacy
• LinkedInlinkedin.com/company/boothwyn-pharmacy
• Instagraminstagram.com/boothwyn_pharmacy
• Xx.com/Boothwyn_Rx

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boothwyn Pharmacy